Evidence map›Paper›PMID 25192910›Full record

ArticleCellular signalling2014

TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.

Mingli Liu, Koichi Inoue, Tiandong Leng, Shanchun Guo, Zhi-gang Xiong

Open access · hybridAbstract read
In one paragraph

Article in Cellular signalling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Roles of TRPM channels in glioma.Cancer biology & therapy · 2024
    Review
  13. Review
  14. Review
  15. The Role of TRPM7 in Oncogenesis.International journal of molecular sciences · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Ion Channels in Gliomas-From Molecular Basis to Treatment.International journal of molecular sciences · 2023
    Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mingli LiuNeuroscience Institute, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA; Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA. Electronic address: mliu@msm.edu.
Koichi InoueNeuroscience Institute, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA.
Tiandong LengNeuroscience Institute, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA.
Shanchun GuoDepartment of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA; Parker H. Petit Institute for Bioengineering & Biosciences, Department of Chemistry and Biochemistry, Georgia Institute of Technology, 315 Ferst Dr. NW, Atlanta, GA 30332, USA.
Zhi-gang XiongNeuroscience Institute, Morehouse School of Medicine, 720 Westview Drive Southwest, Atlanta, GA 30310, USA. Electronic address: ZXiong@msm.edu.
Morehouse School of Medicine · USGeorgia Institute of Technology · US

Funding

Morehouse School of Medicine Center of Excellence Research Endowment ProgramS21MD000101 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2001 to 2015
$74.3M
TRANSCRIPTION FACTORS AND PROSTATE CANCERG12RR003034 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI POWELL, MICHAEL D · 1986 to 2011
$32.4M
Research Desogn and Biostatistics CoreU54MD007588 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI KLEMENT, BRENDA · 2012 to 2018
$24.8M
Research Training & Career Development ProgramU54CA118638 · NCI · MOREHOUSE SCHOOL OF MEDICINE · PI Brian M. Rivers · 2005 to 2026
$22.7M
WARCEFU54RR026137 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI CONERLY HOLLIDAY, RHONDA C · 2009 to 2011
$14.6M
Program Evaluation - Internal & External U54NS083932 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI MACLEISH, PETER RAYMOND · 2013 to 2017
$7.7M
ASICs and increased ischemic brain injury in diabetic conditionR01NS066027 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI XIONG, ZHIGANG · 2011 to 2015
$1.6M
RENOV OF MEDICAL SCI &EDUCATION BLDGS: RETINAL CELLSC06RR018386 · NCRR · MOREHOUSE SCHOOL OF MEDICINE · PI SULLIVAN, LOUIS W. · 2002 to 2002
$1.3M
NCI NIH HHS U54 CA118638NCRR NIH HHS 1C06 RR18386NCRR NIH HHS C06 RR018386NCRR NIH HHS G12 RR003034NCRR NIH HHS RR03034NCRR NIH HHS U54 RR026137NIMHD NIH HHS S21 MD000101NIMHD NIH HHS U54 MD007588NINDS NIH HHS R01 NS066027NINDS NIH HHS R01NS066027NINDS NIH HHS U54 NS083932NINDS NIH HHS U54NS083932
6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults with median survival time of 14.6 months. A small fraction of cancer stem cells (CSC) initiate and maintain tumors thus driving glioma tumorigenesis and being responsible for resistance to classical chemo- and radio-therapies. It is desirable to identify signaling pathways related to CSC to develop novel therapies to selectively target them. Transient receptor potential cation channel, subfamily M, member 7, also known as TRPM7 is a ubiquitous, Ca(2+) and Mg(2+) permeable ion channels that are special in being both an ion channel and a serine/threonine kinase. In studies of glioma cells silenced for TRPM7, we demonstrated that Notch (Notch1, JAG1, Hey2, and Survivin) and STAT3 pathways are down regulated in glioma cells grown in monolayer. Furthermore, phospho-STAT3, Notch target genes and CSC markers (ALDH1 and CD133) were significantly higher in spheroid glioma CSCs when compared with monolayer cultures. The results further show that tyrosine-phosphorylated STAT3 binds and activates the ALDH1 promoters in glioma cells. We found that TRMP7-induced upregulation of ALDH1 expression is associated with increases in ALDH1 activity and is detectable in stem-like cells when expanded as spheroid CSCs. Finally, TRPM7 promotes proliferation, migration and invasion of glioma cells. These demonstrate that TRPM7 activates JAK2/STAT3 and/or Notch signaling pathways and leads to increased cell proliferation and migration. These findings for the first time demonstrates that TRPM7 (1) activates a previously unrecognized STAT3→ALDH1 pathway, and (2) promotes the induction of ALDH1 activity in glioma cells.

Indexed as

Signal TransductionAldehyde Dehydrogenase 1 FamilyBase SequenceBrain NeoplasmsCell Line, TumorCell MovementFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticGene Knockdown TechniquesGliomaHumansIsoenzymesModels, BiologicalMolecular Sequence DataNeoplasm InvasivenessNeoplastic Stem CellsAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanIsoenzymesPhosphotyrosineProtein Serine-Threonine KinasesReceptors, NotchRetinal DehydrogenaseRNA, MessengerSTAT3 Transcription FactorTRPM7 protein, humanTRPM Cation ChannelsALDH1Cancer stem cellGlioblastoma multiformeNotchSTAT3TRPM7

Identifiers

PMID25192910
PMCPMC4405379
OpenAlexW1977986556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.